Suzanne Conzen, MD Dr. de Jong treats children with all types of cancers and blood diseases, as well as hematopoietic stem cell trans
plant patients. She has specialized expertise in autoimmune blood diseases and bleeding and clotting disorders.

Dr. de Jong's research focuses on hematopoietic stem cells and understanding the genes that can cause leukemia. She is developing novel strategies to discover new regulatory mechanisms that drive normal hematopoietic stem cells, and to understand how those mechanisms can lead to leukemia when they function abnormally. Dr. de Jong's research is currently funded by the National Institutes of Health. She also has many published research articles and chapter reviews.

Dr. de Jong attended medical school at the University of Wisconsin and did her residency at Children's Hospital Boston.